1
BARASCH Jonathan, QIU Andong: Proteines ngal mutantes et leurs utilisations, Mutant ngal proteins and uses thereof. The Trustees Of Columbia University In The City Of New York, BARASCH Jonathan, QIU Andong, LOVE Jane M, December 1, 2011: WO/2011/149962 (3 worldwide citation)

In one aspect the present invention is directed to mutant NGAL proteins that have the ability to bind to siderophores, such as enterochelin, and to chelate and transport iron, and that are excreted in the urine. Such NGAL mutants, and complexes thereof with siderophores, can be used to clear excess ...


2
Jonathan Barasch, Andong Qiu: Mutant NGAL proteins and uses thereof. THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, Wilmer Cutler Pickering Hale and Dorr, April 18, 2017: US09624281

In one aspect the present invention is directed to mutant NGAL proteins that have the ability to bind to siderophores, such as enterochelin, and to chelate and transport iron, and that are excreted in the urine. Such NGAL mutants, and complexes thereof with siderophores, can be used to clear excess ...


3

4
MUTANT NGAL PROTEINS AND USES THEREOF. The Trustees of Columbia University in the City of New York, August 22, 2013: US20130217637-A1

In one aspect the present invention is directed to mutant NGAL proteins that have the ability to bind to siderophores, such as enterochelin, and to chelate and transport iron, and that are excreted in the urine. Such NGAL mutants, and complexes thereof with siderophores, can be used to clear excess ...


5
MUTANT NGAL PROTEINS AND USES THEREOF. November 19, 2015: US20150329607-A1

In one aspect the present invention is directed to mutant NGAL proteins that have the ability to bind to siderophores, such as enterochelin, and to chelate and transport iron, and that are excreted in the urine. Such NGAL mutants, and complexes thereof with siderophores, can be used to clear excess ...



Click the thumbnails below to visualize the patent trend.